B
Benny Zee
Researcher at The Chinese University of Hong Kong
Publications - 299
Citations - 28990
Benny Zee is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 79, co-authored 278 publications receiving 26446 citations. Previous affiliations of Benny Zee include National Institutes of Health & Queen's University.
Papers
More filters
Journal ArticleDOI
Interpreting the significance of changes in health-related quality-of-life scores.
TL;DR: The significance of changes in QLQ-C30 scores can be interpreted in terms of small, moderate, or large changes in quality of life as reported by patients in the SSQ.
Journal ArticleDOI
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
Brian O'Sullivan,Aileen M. Davis,Robert E. Turcotte,Robert E. Turcotte,Robert S. Bell,Robert S. Bell,Charles Catton,Pierre Chabot,Jay S. Wunder,Jay S. Wunder,Rita A. Kandel,Rita A. Kandel,Karen Goddard,Anna Sadura,Joseph L. Pater,Benny Zee +15 more
TL;DR: Overall survival was slightly better in patients who had preoperative radiotherapy than in those who had postoperative treatment, and the size and anatomical site of the tumour was also significant risk factors in multivariate analysis.
Journal ArticleDOI
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.
Rossa W.K. Chiu,K.C. Allen Chan,Yuan Gao,Virginia Y. M. Lau,Wenli Zheng,Tak Yeung Leung,Chris H. F. Foo,Bin Xie,Nancy B.Y. Tsui,Fiona M.F. Lun,Benny Zee,Tze K. Lau,Charles R. Cantor,Y.M. Dennis Lo +13 more
TL;DR: Massively parallel plasma DNA sequencing represents a new approach that is potentially applicable to all pregnancies for the noninvasive prenatal diagnosis of fetal chromosomal aneuploidies.
Journal ArticleDOI
Randomized Intergroup Trial of Cisplatin–Paclitaxel Versus Cisplatin–Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
Martine Piccart,Kamma Bertelsen,Keith James,Jim Cassidy,Constantino Mangioni,Ernst Simonsen,Gavin Stuart,Stan B. Kaye,Ignace Vergote,René Blom,R. Grimshaw,Ronald J. Atkinson,Ken D. Swenerton,Claes G. Tropé,M. Nardi,Janne Kærn,Salvatore Tumolo,Petra Timmers,Josee Anne Roy,François Lhoas,Berit Lindvall,Monica Bacon,Angelo Birt,Joern Erik Andersen,Benny Zee,James Paul,Benoit Baron,Sergio Pecorelli +27 more
TL;DR: There is strong and confirmatory evidence from two large randomized phase III trials to support paclitaxel-cisplatin as the new standard regimen for treatment of patients with advanced ovarian cancer.
Journal ArticleDOI
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.
Pascal Piedbois,Ph. Rougier,Marc Buyse,J.P. Pignon,Louise Ryan,R Hansen,Benny Zee,B Weinerman,J Pater,Cynthia G. Leichman,John S. Macdonald,Jacqueline Benedetti,J Lokich,J Fryer,G Brufman,R Isacson,Agnès Laplanche,E Levy +17 more
TL;DR: 5-FU CI is superior to 5-FU bolus in terms of tumor response and achieves a slight increase of overall survival, and the hematologic toxicity is much less important in patients who receive 5-fu CI, but hand-foot syndrome is frequent in this group of patients.